Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Geneticist Appointed as Hughes Investigator

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Neil Hunter has been named as a Howard Hughes Medical Institute investigator, an honor reserved for scientists who exhibit exceptionally original thinking.

Hunter studies the most fundamental processes of how genes are shuffled and passed to the next generation.

The HHMI will pay Hunter's salary and research laboratory expenses, including salaries for research staff, for five years. He will then have an opportunity to apply for renewal of the grant.

"I'm delighted to congratulate Professor Hunter on this appointment, which underlines the growing prestige and influence of UC Davis as a center for biomedical research," said UC Davis Chancellor Linda P.B. Katehi.

Hunter is the first UC Davis faculty member to be appointed to the prestigious HHMI Investigator program and one of just 27 new HHMI investigators announced today (May 9) from a field of 1,155 applicants. In 2009, Hunter was named an early career scientist by the institute.

"Being named as an HHMI investigator is an exceptional honor for Neil, as well as for the UC Davis College of Biological Sciences," said James E. K. Hildreth, dean of the college. "He is a leader in the field of DNA recombination and his research has major implications for understanding many diseases, including cancer. Support from HHMI will allow him to sustain his research excellence for many years to come."

Robert Tjian, HHMI president, said the organization has a very simple mission. "We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes," Tjian said.

Under the terms of the award, Hunter will be an employee of HHMI working at UC Davis. There are approximately 330 HHMI investigators in the U.S. who are urged to "take risks, to explore unproven avenues, and to embrace the unknown — even if it means uncertainty or the chance of failure," according to the institute's website. There are no annual reports, and investigators are free to explore and change their research direction.

Hunter said that being affiliated with HHMI has been one of the most rewarding experiences of his scientific career, and thanked those who have helped him along the way. "I would not have received this honor without the understanding, encouragement and support of my family, colleagues, department chairs and deans, both past and present," he said.

HHMI investigators are expected to devote about three-quarters of their time to research, but also to participate in other faculty duties including teaching and service.

Hunter is studying a fundamental problem in biology: how cells shuffle their DNA and distribute exactly the right number of chromosomes to each sperm or egg cell. When cells divide to make sperm and eggs, how do they make sure that each cell obtains one full set of chromosomes?

When this process goes wrong, it can lead to miscarriage and developmental defects such as Down syndrome. It is estimated that around half of the roughly 1 million miscarriages that occur in the U.S. each year are due to a chromosomal imbalance. The risk increases with the mother's age.

Organisms from yeast to humans make their gametes (spores in yeast, sperm and eggs in humans) through a process called meiosis. While most body cells contain pairs of each chromosome, sperm and eggs have one copy of each, so that the fertilized egg ends up with one set of chromosomes from each parent.

During meiosis, the matching pairs of maternal and paternal chromosomes line up together, and their DNA strands interact by a process called recombination. This allows the chromosomes to exchange DNA with their paired partner, an event called a crossover.

"Initially there are hundreds of DNA breaks throughout the chromosomes, but only a few become crossovers," Hunter said.

Crucially, there has to be at least one crossover between each chromosome pair, or they will not line up properly, and gametes will receive the wrong number of chromosomes.

"I'm interested in how crossovers are made — how the process is wired in such a way that each pair of chromosomes always gets at least one crossover, even through the total number of crossovers in a cell is quite low. It's a fundamental process that we’re far from understanding," Hunter said. The crossover process was first proposed in 1909 by Belgian scientist Frans Janssens, who observed crossovers in cells undergoing meiosis from the Californian salamander.

Hunter is also a member of the UC Davis Comprehensive Cancer Center. In 2011, two UC Davis plant biologists, Professor Jorge Dubcovsky, Department of Plant Sciences, and the late Simon Chan, Department of Plant Biology, were among the first-ever class of HHMI-GBMF investigators, funded jointly by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation to support research leading to improved crops.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Monday, August 03, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
Friday, July 24, 2015
Printed "Smart Cap" Detects Spoiled Food
It might not be long before consumers can just hit “print” to create an electronic circuit or wireless sensor in the comfort of their homes.
Tuesday, July 21, 2015
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
Friday, July 03, 2015
Delivering Drugs to the Right Place
Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.
Monday, June 29, 2015
The Deep Carbon Cycle
Over billions of years, the total carbon content of the outer part of the Earth—in its upper mantle, crust, oceans and atmospheres—has gradually increased, scientists report.
Tuesday, June 23, 2015
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Thursday, June 11, 2015
Engineers Crack DNA Code of Autoimmune Disorders
Researchers have identified an unexpectedly general set of rules that determine which molecules can cause the immune system to become vulnerable to the autoimmune disorders lupus and psoriasis.
Wednesday, June 10, 2015
Genetic Markers for Detecting and Treating Ovarian Cancer
Custom bioinformatics algorithm identifies human mRNAs that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Wednesday, May 27, 2015
Researchers Reverse Bacterial Resistance to Antibiotics
Evidence continues to surface that supports the premise that antibiotics which have been out of use could still be effective in treating drug-resistant bacteria.
Friday, May 08, 2015
Industry-Sponsored Academic Inventions Spur Increased Innovation
Analysis questions assumption that corporate support skews science toward inventions that are less useful than those funded by the government or non-profit organizations.
Monday, March 24, 2014
May the Cellular Force be With You
Like tiny construction workers, cells sculpt embryonic tissues and organs in 3D space.
Friday, December 13, 2013
Grant Supports Creation of Patient-Derived Stem Cell Lines
Researchers have received a two-year, $600,000 grant from the National Institute on Aging to develop and study patient-derived stem cell lines.
Thursday, December 12, 2013
Prostate Cancer Stem Cells are a Moving Target
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Friday, December 06, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!